BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 24407711)

  • 1. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
    Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
    Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
    Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
    Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
    Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
    J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
    J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
    Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
    J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
    Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Lopez Hänninen E; Felix R
    Strahlenther Onkol; 2004 May; 180(5):274-80. PubMed ID: 15127157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma: CT-guided High-Dose Rate Brachytherapy (CT-HDRBT) for Limited (<4 cm) and Large (>4 cm) Tumors.
    Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Feldhaus F; Denecke T; Wieners G; Hamm B; Gebauer B
    Anticancer Res; 2018 Oct; 38(10):5843-5852. PubMed ID: 30275209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatic metastases from gastric or gastroesophageal adenocarcinoma with computed tomography-guided high-dose-rate brachytherapy (CT-HDRBT).
    Geisel D; Denecke T; Collettini F; Grieser C; Wust P; Thuss-Patience P; Hamm B; Gebauer B
    Anticancer Res; 2012 Dec; 32(12):5453-8. PubMed ID: 23225451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
    Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
    Pech M; Wieners G; Kryza R; Dudeck O; Seidensticker M; Mohnike K; Redlich U; Rühl R; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 Jun; 184(6):302-6. PubMed ID: 18535805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
    Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
    Steffen IG; Wust P; Rühl R; Grieser C; Schnapauff D; Lüdemann L; Grabik W; Ricke J; Amthauer H; Hamm B; Hänninen EL; Denecke T
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1178-85. PubMed ID: 20056343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
    Peters N; Wieners G; Pech M; Hengst S; Rühl R; Streitparth F; Lopez Hänninen E; Felix R; Wust P; Ricke J
    Strahlenther Onkol; 2008 Jun; 184(6):296-301. PubMed ID: 18535804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.